Market revenue in 2023 | USD 1,542.2 million |
Market revenue in 2030 | USD 3,957.0 million |
Growth rate | 14.4% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.06% in 2024. Horizon Databook has segmented the Asia Pacific biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific region is estimated to register the fastest growth rate during the projected period. The fastpaced growth of this region is expected to be mainly driven by China and India. Key factors driving the industry growth include increase in access to technologies, a large patient pool, and improvement in healthcare infrastructure.
The increasing adoption of biochip technology in emerging markets by mature players to refine processes is also a significant factor driving the region’s growth. Moreover, the flourishing biotechnology sector, presence of a large number of research & academic institutes, and significant investments by market participants are projected to drive the region’s market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biochip market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account